Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Shares Outstanding (2019 - 2025)

Volitionrx (VNRX) has disclosed Shares Outstanding for 8 consecutive years, with $109.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding rose 18.65% year-over-year to $109.6 million, compared with a TTM value of $109.6 million through Sep 2025, up 18.65%, and an annual FY2024 reading of $96.1 million, up 17.34% over the prior year.
  • Shares Outstanding was $109.6 million for Q3 2025 at Volitionrx, up from $104.0 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $109.6 million in Q3 2025 and bottomed at $52.9 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $74.0 million, with a median of $78.1 million recorded in 2023.
  • The sharpest move saw Shares Outstanding grew 1.32% in 2022, then soared 45.11% in 2023.
  • Year by year, Shares Outstanding stood at $53.8 million in 2021, then rose by 7.63% to $57.9 million in 2022, then skyrocketed by 41.51% to $81.9 million in 2023, then grew by 17.34% to $96.1 million in 2024, then rose by 14.07% to $109.6 million in 2025.
  • Business Quant data shows Shares Outstanding for VNRX at $109.6 million in Q3 2025, $104.0 million in Q2 2025, and $100.7 million in Q1 2025.